Boris Farber

This inventor holds 19 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Bjr Sensors LLC, Zircoa, Inc., Other. Active years: 2007-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boris Farber. Retrieved from https://idiyas.com/inventor/boris-farber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19

% Patents Active = 89.5

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 82(Granted Patents)

Location History:

Solon, OH (US) (2007 - 2020)
Brooklyn, NY (US) (2014 - 2022)

Company Filing History:

11 out of 834,708

Other

patents

Years Active: 2007-2022

Loading Chart...

Areas of Expertise:

Immunomodulatory

Antiviral Properties

Pharmaceutical Composition

Oligopeptides

Vaccines

Nanostructures

Sensor Design

Stem Cell Division

Cosmetological Composition

Mixed Gas Measurements

Signal Output Stability

Grinding Beads

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11446338 - Food, cosmetic and pharmaceutical formulation with an immunomodulatory and protective anti-viral effect (2022-09-20),

2. 11339502 - Combinatorial derivatives of oligopeptides having antiviral properties (2022-05-24),

3. 11229622 - Cosmetological and pharmaceutical composition based on combinatorial quercetin derivative (2022-01-25),

4. 11213579 - Vaccines with enhanced immunogenicity, low allergenicity and reactogenicity (2022-01-04),

5. 11191806 - Polymyxin-based pharmaceutical composition for treating infectious diseases (2021-12-07),

6. 11191767 - Pharmaceutical composition for stimulating stem cell division and suppressing bacterial virulence (2021-12-07),

7. 11160878 - Supramolecular systems based on dynamic self-organizing nanostructures with antiviral properties (2021-11-02),

8. 11053608 - Combinatorial derivatives of RNA oligonucleotides (2021-07-06),

9. 10837940 - Planar sensor design and pulse discharge technique hardware (2020-11-17),

10. 10451582 - Planar lambda sensor design to be used with pulse discharge technique for concurrent NO/NHmeasurements (2019-10-22),

11. 10436739 - Low cost, fast and sensitive NOx and NH3 sensor (2019-10-08),

12. 10180408 - Method of sensor conditioning for improving signal output stability for mixed gas measurements (2019-01-15),

13. 10156545 - Method of sensor conditioning for improving signal output stability for mixed gas measurements (2018-12-18),

14. 9304101 - Method of sensor conditioning for improving signal output stability for mixed gas measurements (2016-04-05),

15. 8846064 - Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly (2014-09-30),

Title: Boris Farber: Pioneering Innovations in Biotechnology and Antiviral Research

Introduction:

Boris Farber, a visionary inventor based in Solon, OH, is widely recognized for his groundbreaking contributions to the fields of biotechnology and antiviral research. With a total of 19 patents to his name, Farber's passion for innovation and unwavering dedication to excellence have positioned him as a trailblazer in the realm of science and technology.

Latest Patents:

Farber's latest patents encompass a range of groundbreaking formulations with immunomodulatory and protective antiviral properties. His invention in the food, cosmetic, and pharmaceutical industries offers new avenues for disease prevention and treatment, particularly in respiratory viral infections. The compositions not only prevent infections by viruses like influenza, rotavirus, and coronavirus but also exhibit superior immune-stimulating effects compared to traditional probiotics.

Career Highlights:

During his illustrious career, Boris Farber has made significant strides in advancing biotechnology and antiviral research. His innovative approach to synthesizing combinatorial derivatives of oligopeptides has revolutionized the field by introducing new mechanisms of action that enhance treatment efficacy and reduce the duration of viral diseases such as influenza and herpes virus infections.

Collaborations:

Farber's collaborative efforts with esteemed colleagues, including Artur Viktorovich Martynov and Sof'ya Farber, have further enriched his research endeavors. By fostering partnerships with like-minded professionals, Farber has been able to leverage collective expertise and drive impactful innovations that have the potential to transform the landscape of modern medicine.

Conclusion:

As Boris Farber continues to push the boundaries of scientific discovery, his legacy as a pioneering inventor in biotechnology and antiviral research remains unparalleled. His visionary work not only inspires the next generation of inventors but also shapes the future of technology in ways that promise to make a lasting impact on global health and well-being.

Profile summary based on public USPTO records.